Antirheumatic in SARS-CoV-2: benefit or risk?

被引：25
作者：
Ferrara, Francesco [1 ]
机构：
[1] Usl Umbria 1, Ple Gambuli, I-06132 Perugia, Italy
来源：
ITALIAN JOURNAL OF MEDICINE | 2020年 / 14卷 / 02期
关键词：
SARS-CoV-2; antirheumatic; COVID-19; infection; immunology; CHLOROQUINE;
D O I：
10.4081/itjm.2020.1290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 16 条
  • [1] Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
    不详
    [J]. PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 9 - 26
  • [2] Chang R, 2020, REPOSITIONING CHLORO, DOI 10.20944/preprints202003.0279.v1
  • [3] Chen X, 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA449, 10.1093/cid/ciaa449.
  • [4] PMCID]
  • [5] Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
    Gao, Jianjun
    Tian, Zhenxue
    Yang, Xu
    [J]. BIOSCIENCE TRENDS, 2020, 14 (01) : 72 - 73
  • [6] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
    Gautret, Philippe
    Lagier, Jean-Christophe
    Parola, Philippe
    Van Thuan Hoang
    Meddeb, Line
    Mailhe, Morgane
    Doudier, Barbara
    Courjon, Johan
    Giordanengo, Valerie
    Vieira, Vera Esteves
    Dupont, Herve Tissot
    Honore, Stephane
    Colson, Philippe
    Chabriere, Eric
    La Scola, Bernard
    Rolain, Jean-Marc
    Brouqui, Philippe
    Raoult, Didier
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
  • [7] Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30211-7, 10.1016/S0140-6736(20)30183-5]
  • [8] Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
    Liu, Jia
    Cao, Ruiyuan
    Xu, Mingyue
    Wang, Xi
    Zhang, Huanyu
    Hu, Hengrui
    Li, Yufeng
    Hu, Zhihong
    Zhong, Wu
    Wang, Manli
    [J]. CELL DISCOVERY, 2020, 6 (01)
  • [9] COVID-19: consider cytokine storm syndromes and immunosuppression
    Mehta, Puja
    McAuley, Daniel F.
    Brown, Michael
    Sanchez, Emilie
    Tattersall, Rachel S.
    Manson, Jessica J.
    [J]. LANCET, 2020, 395 (10229) : 1033 - 1034
  • [10] National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management
    Nicastri, Emanuele
    Petrosillo, Nicola
    Bartoli, Tommaso Ascoli
    Lepore, Luciana
    Mondi, Annalisa
    Palmieri, Fabrizio
    D'Offizi, Gianpiero
    Marchioni, Luisa
    Murachelli, Silvia
    Ippolito, Giuseppe
    Antinori, Andrea
    [J]. INFECTIOUS DISEASE REPORTS, 2020, 12 (01) : 3 - 9
12